Project Manager – HIV Viral Suppression Adherence Toolkit, Centers for Disease Control and Prevention (CDC)

In the era of tenofovir-lamivudine-dolutegravir (TLD), an extremely effective anti-retroviral therapy, individuals living with HIV who do not achieve viral load suppression require personalized, intensive attention to prevent progression of HIV and help overcome barriers to adherence.  However, there are few studies regarding evidence based practices for promoting adherence in this setting.  The goal is to identify the best evidence based practices for promoting ART adherence and share these in an efficient, effective way with our partners in PEPFAR supported countries.

Find more details and instructions for applying in the job posting on 12Twenty. Application deadline is September 16th at 11:59pm!